Browsing: Company

Sleep-health company SomnoMed (ASX:SOM) has been in focus as investors weigh a tempered FY26 Revenue outlook, a Leadership change and a new product launch ahead of the company’s full-year results. SomnoMed, which makes oral devices for treating obstructive sleep apnoea (OSA), has been navigating a period of transition

SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ — Mira, a leading hormonal health company, today announced the launch of a national petition aimed at closing a dramatic gap around hormonal health in sex education in the United States, aligning with the company’s annual Sex Hormones Awareness Week